SYNOPSIS A new method has been developed for the assay of serum pyridoxal using L. casei. Bound pyridoxal phosphate in serum is converted by acid hydrolysis to pyridoxal for which this organism is specific. This method proved to be considerably more sensitive than other methods so far reported in the literature.
Add 16-5 ml 0-2N HCI to each of seven universal containers. Add 0, 0-1, 0-2, 0 4, 0-6, 0-8, and 1-0 ml respectively of working solution' Proceed exactly as for serum. and the concentration of this material increased with length of autoclaving. D-Alanine can replace pyridoxal for growth of L. casei (Snell, 1945) , and this almost certainly explains the falsely high values obtained.
The purpose of the work described in this paper was to investigate the use of L. casei as an assay organism forpyridoxal in serum, and in particular to study whether a full extraction of pyridoxal from serum could be obtained by acid hydrolysing for a shorter period and hence preventing the production of D-alanine. In view of the importance of alanine in the function of B6 in lactic acid organisms (Snell, 1945) , the effect on growth of the addition to the assay medium of the different forms of alanine was studied.
As a result of these studies a specific, sensitive and accurate assay for serum pyridoxal was developed using L. casei. This enabled us to measure accurately the serum pyridoxal concentrations in control subjects and in patients with different diseases. Preliminary results are reported. Table It Preparation of serum and standards by acid hydrolysis ' If serum pyridoxal concentration less than 3 ng/ml use 0-5 ml serum, and if greater than 10 ng/ml use 0-1 ml or less serum. 2Use pyridoxal HCI (Sigma) (121-8 mg equivalent to 100 mg pyridoxal). Two stock solutions, 500 ,ug/ml and 2-5 tsg/ml pyridoxal in 0-02N HCI, which may be kept for one year and one month respectively at 4°C in dark bottles. Freshly made working solution 5 ng/ml in distilled water.
Step Measure growth turbidity in Unicam SP 1300 colorimeter in a 1 cm cell using violet filter, Ilford no. 621 (370-515 m I), using uninoculated serum and standard tube contents as blanks respectively.
8
Plot standard curve on linear graph paper (see Fig. 2A Read strum value from standard curve and multiply by 2 to give ng/ml Assay sera in two different assay batches and take mean Run control sera in every batch. Table III Assay procedure using sterile precautions for steps [1] [2] [3] [4] 'Make double strength medium to 6/5 volume with distilled water and sterilize in bulk at 10 psi for eight minutes (medium autoclaved before dispensing to avoid differences in individual assay tubes due to uneven heating in the autoclave).
2(a) Incubate a disc culture of L. casei in 10 ml sterile inoculum broth (Difco Bactola ctobacilli broth AOAC-0901-15) at 37'C for 16 hours. (b) Transfer 1 ml into 10 ml sterile inoculum broth and incubate at 37°C for six to eight hours. (c) Dilute I ml in 20 ml sterile single-strength medium for inoculum.
The assay organism used was Lactobacillus casei NCIB 8010 (ATCC 7469). It was maintained as dried gelatin discs (Stamp, 1947; Chanarin, Anderson, and Mollin, 1958) . Glass-distilled water produced by the Loughborough all-glass still was used throughout. All glassware and pipettes underwent the rigid cleaning procedure necessary for microbiological assay as described by Waters and Mollin (1961) .
COLLECTION OF BLOOD SAMPLES
Disposable syringes and needles were used to collect venous blood from subjects at least two hours after food. The blood was immediately put into a sterile universal container wrapped in silver paper to protect it from light, allowed to clot, and the serum separated in subdued light. The serum was stored protected from light at -20°C until assayed.
CONTROL SERA Three control sera with pyridoxal concentrations covering the range found in health and disease were set up in every assay batch. A large amount was collected for each control serum and stored at -20°C. in aliquots sufficient for two assays. Details are given in Table I .
METHOD
Details of the extraction of serum pyridoxal and the assay procedure are given in Tables II and  III respectively. As pyridoxal is sensitive to light all procedures were carried out in subdued light, ie, without artificial lighting and screened from direct daylight.
ASSAY MEDIUM
The composition of the medium used (Table IV) is a modification of that used by Waters and Mollin (1961) PYRIDOXAL (ng/lOOml) Fig. 1 The effect of the addition ofL-alanine to the assay medium on growth of L. casei in pyridoxal standards comparing two enzymatic casein hydrolysates which hadpromoted (A) poor growth and (B) apparently good growth when L-alanine was not added to the medium. * 0 No L-alanine in assay medium * 0 L-alanine (02 g per 100 ml) added to medium.
L-alanine was not added to the medium, especially when using casein A, which was the more deficient in L-alanine ( Figure 1 ). This is probably because some L-alanine is provided by the serum itself and takes effect particularly in sera with high pyridoxal concentrations where growth is high and hence L-alanine in the medium is exhausted. The recovery of pyridoxal added to serum was also falsely high.
Effect of heating
Equal quantities of medium were autoclaved by steaming for three minutes and at 10 psi for three, eight, and 15 minutes respectively. Growth in these four media decreased with length of heating. Up to eight minutes of heating the curves were parallel, the lowest growth blank being in the latter. The serum values were unaffected. Growth appeared to be depressed when medium was heated for 15 minutes suggesting some destruction of the nutrients. The most suitable length of autoclaving where the growth blank was reduced was at 10 psi for eight minutes.
PYRIDOXAL STANDARDS
Effect of storage Four separate stock solutions of 500 utg/ml in 0-02N HCI kept at 4°C were each tested after 13, 14, 15, and 16 months respectively and no deterioration was detected as measured by growth of L. casei. Similarly, different solutions of 2-5 /Lg/ml were tested after one, three, and five months and no deterioration was detected.
Effect of light
Pyridoxal standards were exposed to ordinary daylight on a dull day for three and a half hours, and, when compared with standards protected from light, more than half the pyridoxal activity as measured by L. casei was destroyed.
Effect of heating with assay medium Pyridoxal standards were added to the tubes before and after autoclaving with the medium at 10 psi for three minutes. Half the activity of the pyridoxal was destroyed when it was autoclaved together with the medium.
Effect of acid hydrolysis Pyridoxal standards were hydrolysed as described in Table II and growth was compared in these standards with aqueous pyridoxal standards, both sets being added after the medium had been sterilized. The growth was higher in the hydrolysed pyridoxal (Fig. 2) . This effect was not due to autoclaving. If different concentrations of HCl were used, the growth increased within limits in proportion to the concentration of HCI used. However, the precise factor responsible for the increased growth is difficult to assess, because the concentration of HCI used also determined the amount of KOH subsequently required to adjust the pH to 6*4.
SERUM PYRIDOXAL
Effect of storage Serum was stored protected from light and at -20°C for as long as two years and there was no detectable deterioration in the pyridoxal concentration.
Hydrolysates of the control sera were stored as above for several weeks and then assayed together with fresh hydrolysates of the same sera. Hydrolysates which had been stored for up to six weeks showed no significant deterioration but after longer storage the pyridoxal concentration gradually decreased. Dilution agreement Assay values were the same when (1) different amounts of serum were hydrolysed (0 5 ml. and less); (2) different amounts of the hydrolysate were assayed. In view of the growth effect of the HC1/KOH mixture used in hydrolysis it was essential that the assay values for serum were read from standards containing the same volume of the HCI/KOH mixture.
In practice, the volume of hydrolysate assayed was fixed at 2 ml and the dilution was varied by changing the volume of serum hydrolysed, eg, 0'25 ml of serum hydrolysed gives a final dilution of 1 in 200; 0 5 ml serum gives a final dilution of 1 in 100.
IDENTIFICATION OF L.casei GROWTH FACTOR IN SERUM
The assay medium contained no pyridoxal, but as far as is known contained all the other factors likely to be found in body fluids, including the other vitamins which were necessary for the growth of L. casei. To confirm that the growth factor in serum hydrolysates was pyridoxal the following experiment was done.
Gel filtration using Sephadex G-10 was carried out on two 5 ml concentrates from pooled hydrolysates of 2 5 ml of normal serum (1) alone and (2) with added pyridoxal. Fractions, each of 6 ml, were eluted with a 0-1 M phosphate buffer (pH 6 0). All fractions up to and including the last peak of ultraviolet absorbancy at 280 m,u were assayed with L. casei.
In the serum hydrolysate with no added pyridoxal, a small peak of growth was associated with the 'run-through' peak, but most of the growth factor was held on the column and eluted fairly sharply in the region of substances having the molecular weight of pyridoxal (167). In the hydrolysate to which pyridoxal had been added, the small 'run-through' peak was slightly increased, but the rest of the increase in growth factor for L. casei eluted in exactly the same position as in the serum sample without added pyridoxal. This identity of molecular size determined by gel filtration strongly suggested that the growth factor in serum hydrolysates was B6 and hence pyridoxal, being the only form to which L. casei responds at these levels. This was further supported by subjecting the peak fractions before assay to ultraviolet light exposure sufficient to destroy B6 and finding that only a very small percentage (<5%) of the growth remained in these fractions. It was also shown that the addition of 3H labelled pyridoxine to a serum hydrolysate resulted in the appearance of a sharp peak of counts which eluted in the same position as did the growth factor for L. casei.
ACCURACY OF METHOD

Reproducibility
The three control sera mentioned under Materials and Methods were assayed in 30 consecutive assay batches and during that period four different workers carried out the assays. The results are summarized in Table I . A serum was extracted and assayed 12 times in the same batch and the reproducibility was good. The range was 8-5-10 4 (mean 9-5 and SD ± 0-6 ng/ml). ¶ Recovery of added pyridoxal The recovery of pyridoxal added to serum (10 ng/ml) ranged from 82 to 120% (all but five fell between 90 and 110%). The mean recovery was 100-1% and the SD ± 7-7%. age groups there were not sufficient subjects to justify calculating the mean.
Sex differences
The mean serum pyridoxal concentrations were higher in men than in women in the three age groups and the means were as follows: 20 to 29 years 9-1 and 6 5 ng/ml, and the difference was highly significant (p < 0001); 30 to 39 years 6-4 and 5 3 ng/ml, but there were too few subjects to prove these significantly different; 60 years and over 3 9 and 3-5 ng/ml, and these were not significantly different (0-4 > p > 0-3).
Age differences
There was a steep fall in the mean serum pyridoxal concentrations from the age of 20 to over 60 years (Fig. 3) . The means in the three age groups decreased as follows: men 9-1 to 6-4 to 3 9 ng/ml, and the differences were highly significant (p < 0-001); women 6-5 to 5-3 to 3-5 ng/ml, and the difference between the last two means was statistically significant (0-01 > p > 0-001 (Fig. 4) .
COMPARISON OF SERUM PYRIDOXAL WITH PLASMA PYRIDOXAL PHOSPHATE MEASUREMENTS IN CONTROL SUBJECTS
These results in control subjects are compared with those obtained by another worker (Hamfelt, 1964) , who measured plasma pyridoxal phosphate in control subjects using an enzymatic method ( Twelve of the 16 patients with coeliac disease were untreated and all but two of these patients, that is 83%, had borderline or subnormal concentrations, but these were not as consistently low as in Crohn's disease. The four patients who had been on a gluten-free diet had concentrations well within the control range. In the pregnant women all 13 had subnormal concentrations.
Discussion ASSAY METHOD
The present observations confirmed those of Snell (1945) that D-alanine could replace pyridoxal for growth of L. casei when the assay medium contained an enzymatic casein hydrolysate. However, contrary to observations by other workers, the addition of L-alanine to the medium also enhanced growth, but only in the presence of pyridoxal, the increase being in proportion to the pyridoxal concentration. As with Streptococcus faecalis R therefore, L. casei appears to require B6 as the coenzyme for the racemase that converts L-to D-alanine, which then becomes available to the organism (Storvick and Peters, 1964 sensitivity, accuracy, and reproducibility of the method.
The method of maintenance of the organism in disc form (Stamp, 1947; Chanarin et al, 1958) is to be highly recommended in preference to a continuous subculturing method. It is simpler and there is less likelihood of contamination. There was no evidence that the organism was affected if maintained in disc form for up to 20 months.
Pyridoxal, whether in aqueous solution or in serum, remained stable, provided that it was protected from light, and this was a great advantage in the assay of serum B6. It was important not to autoclave pyridoxal solutions with the assay medium, for the presence of amino acids appears to result in the transfer of amino groups to pyridoxal which converts it to pyridoxamine (Snell, 1944) . This form of B6 does not support growth of L. casei at levels normally found in the body. The fact that pyridoxal in serum hydrolysates deteriorated after storage for six weeks may be due to the contact with amino acids resulting from the hydrolysis of the serum.
The conditions of acid hydrolysis chosen for extraction of free pyridoxal from serum involved a smaller amount of serum (0-25 ml) than had been used by others and also a small volume of acid. The time of autoclaving could also be reduced to one hour, as there was no difference in the assay value when autoclaved at 15 psi over a range of one half to two hours. This is important, for the use of L. casei as assay organism for serum pyridoxal (Storvick and Peters, 1964) was invalidated by the production of D-alanine due to a hydrolysis process lasting longer than two hours (Haskell and Wallnofer, 1967) .
Using the present method of hydrolysis to extract serum pyridoxal, the recovery of pyridoxal added to serum was 100% and assay values were reproducible in spite of a high final dilution of I in 200 or 1 in 100 in the assay tube. However, the conversion of pyridoxal phosphate standards to pyridoxal was not quite complete under these conditions and averaged 87%. In preliminary studies in this laboratory using Streptococcus faecium, which measures both pyridoxal and pyridoxamine (Gregory, 1959) , assay values were the same as with L. casei which suggests that pyridoxamine is not present in an acid hydrolysate of serum under normal conditions. These observations are consistent with those of Kelsay et al (1968) , who could isolate only pyridoxal in acid hydrolysates of whole blood by ion exchange chromatography.
As the present assay results based on acid hydrolysis of serum are similar to those obtained by the majority of enzymatic methods of measuring pyridoxal phosphate in serum or plasma (eg, Baker, Frank, Ning, Gellene, Hutner, and Leevy (1966) used the far less sensitive assay organism, Tetrahymena pyriformis, and also obtained higher values.
The present observations have shown that both age and sex affect the serum pyridoxal concentration. When equal numbers of men and women were grouped together according to age, there was a marked fall in the serum pyridoxal with increasing age and the mean concentrations for corresponding age groups were similar to those reported by Hamfelt (1964) . Walsh (1966) also observed a marked fall with increasing age, but even earlier Boxer et al (1957) had suggested this effect of age based on his observation that leucocyte pyridoxal phosphate was higher in children than in adults. Furthermore, Ranke, Tauber, Horonick, Ranke, Goodhart, and Chow (1960) found increased xanthurenic acid excretion after tryptophan loading and decreased serum GOT levels with increasing age, which disappeared when B6 was given.
When the serum pyridoxal concentrations were analysed with regard to sex, the mean concentrations in men were higher than in women. This was most obvious between the ages of 20 and 40 years, but was not significant after the age of 60 years. It is not possible from our figures to tell whether the difference between sexes persisted until the menopause. Wachstein et al (1960) also observed that the mean plasma pyridoxal phosphate concentration in women was lower than that in men, though they made no mention of the age of the subjects.
The explanation for the marked difference in the levels of young men and women is uncertain, but could possibly be related to an increased requirement for B6 in women of childbearing age. Furthermore, the possible effect of oral contraceptives has not been investigated in the present study.' The reason for the fall in the serum pyridoxal with increasing age is also uncertain. This has been discussed at length by Hamfelt (1964) , who mentioned various possibilities, such as defective nutrition, absorption or phosphorylation of the vitamin to its active form, or increased urinary loss. Another possibility is a decrease in the transport protein to which the compound is bound. However, further studies are needed to elucidate these observations. Patients with various conditions Serum pyridoxal concentrations were measured in sideroblastic anaemia because some patients with this condition have been found to respond to treatment with pyridoxine. Sixteen of the 26 patients studied (62% ) had subnormal levels.
Sideroblastic anaemia has also been reported in rheumatoid arthritis (MacGibbon and Mollin, 1965) , and there is other evidence of possible B6 'See Addendum. deficiency, such as abnormal tryptophan loading tests (Bett, 1962; Flinn, Price, Yess, and Brown, 1964; Pinals, 1964) and decreased excretion of B6 compounds in the urine (McKusick, Sherwin, Jones, and Hsu, 1964) . The present study provides further evidence of possible Be deficiency in this condition, in that 30 of the 31 patients (97%) had borderline or subnormal serum pyridoxal levels.
Crohn's disease, like rheumatoid arthritis, is an inflammatory disorder. A high incidence of subnormal serum folate levels has already been demonstrated in this condition (Hoffbrand, Stewart, Booth, and Mollin, 1968) , and in the present study 44 of the 48 patients studied (92%) had borderline or subnormal pyridoxal concentrations. In particular very low levels were found in the young patients.
Sideroblastic anaemia with pyridoxine deficiency has been reported in an adult with coeliac disease, and this completely disappeared when the patient was put on a gluten-free diet (Dawson, Holdsworth, and Pitcher, 1964) . Baker and Sobotka (1962) mentioned 'low circulating levels of vitamin B6' in this condition (non-tropical sprue). The tryptophan loading test may also be abnormal in this condition (Kowlessar, Haeffner, and Benson, 1964) , and evidence of malabsorption of B6 has been reported by Brain and Booth (1964) using tritiated pyridoxine. In this study, 10 of the 12 (83%O) untreated patients with coeliac disease had subnormal pyridoxal levels, while four other patients who had been treated with a gluten-free diet all had normal levels.
Finally, pregnant women were studied because low plasma and leucocyte pyridoxal phosphate concentrations were found in the last trimester by Wachstein et al (1960) , and abnormal loading tests have also been reported (Wachstein and Gudaitis, 1952; Brown, Thornton, and Price, 1961) . Further, Karlin, Croizat, Revol, Pommatau, Viala, and Dumont (1968) showed abnormal pyridoxine load tests in postpartum subjects, using S. carlsbergensis to assay serum before and after a dose of pyridoxine. The 13 pregnant women in the present study all had subnormal levels.
The cause of the subnormal serum pyridoxal concentrations in these various conditions is not certain. An increased requirement for B6 may be reflected in the low serum levels of the patients with rheumatoid arthritis, Crohn's disease, and in pregnancy, while malabsorption probably played a part in coeliac disease. Furthermore, an inadequate dietary intake of B6 may have been a contributory factor in all these groups. However, the clinical significance of a subnormal serum pyridoxal concentration is still uncertain, but the fact that B6-responsive anaemias have been associated with most of these conditions suggests that an alteration in B6 metabolism may occasionally produce serious haematological effects.
